Fahdah Ayed Alshammari

Dr. Fahdah Ayed Alshammari


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2022 in Life
Verified
Journal Article
Open access
PDF file
Hammad Ur Rehman BajwaHammad Ur Rehman Bajwa
Hammad Ur Rehman Bajwa
MKMuhammad kasib Khan
Muhammad kasib Khan
ZAZaheer Abbas
Zaheer Abbas
RRRoshan Riaz
Roshan Riaz
Tauseef RehmanTauseef Rehman
Tauseef Rehman
Abdulaziz AlouffiAbdulaziz Alouffi
Abdulaziz Alouffi
Protozoa, helminths and ectoparasites are the major groups of parasites distributed worldwide. Currently, these parasites are treated with chemotherapeutic antiprotozoal drugs, anti-helminthic and anti-ectoparasitic agents, but, with the passage of time, resistance to these drugs has developed due to overuse. In this scenario, nanoparticles are proving to be a major breakthrough in the treatment and control of parasitic diseases. In the last decade, there has been enormous development in the field of nanomedicine for parasitic control. Gold and silver nanoparticles have shown promising results in the treatments of various types of parasitic infections. These nanoparticles are synthesized through the use of various conventional and molecular technologies and have shown great efficacy. They work in different ways, that include damaging the parasite membrane, DNA (Deoxyribonucleic acid) disruption, protein synthesis inhibition and free-radical formation. These agents are effective against intracellular parasites as well. Other nanoparticles, such as iron, nickel, zinc and platinum, have also shown good results in the treatment and control of parasitic infections. It is hoped that this research subject will become the future of modern drug development. This review summarizes the methods that are used to synthesize nanoparticles and their possible mechanisms of action against parasites.

8 March 2023 in Separations
Verified
Journal Article
Open access
PDF file
Awais KhalidAwais Khalid
Awais Khalid
Pervaiz AhmadPervaiz Ahmad
Pervaiz Ahmad
RMRoomia Memon
Roomia Memon
LGLamyaa Gado
Lamyaa Gado
Mayeen Uddin KhandakerMayeen Uddin Khandaker
Mayeen Uddin Khandaker
ATAbdelmajid Timoumi
Abdelmajid Timoumi
Renewable energy can be harnessed from wastewater, whether from municipalities or industries, but this potential is often ignored. The world generates over 900 km3 of wastewater annually, which is typically treated through energy-consuming processes, despite its potential for energy production. Environmental pollution is a most important and serious issue for all and their adulterations to the aquatic system are very toxic in very low concentrations. Photocatalysis is a prominent approach to eliminating risky elements from the environment. The present study developed Zinc oxide (ZnO), Copper-doped Zinc oxide (CuZnO), and Cobalt-doped Zinc oxide (CoZnO) nanostructures (NSs) by facile hydrothermal route. The crystalline and structural stability of the synthesized nanostructures were evident from XRD and FESEM analysis. Metal, and oxygen bond and their interaction on the surfaces and their valency were explored from XPS spectra. Optical orientations and electron movements were revealed from UV-Visible analysis. After 100 min exposure time with 1 g of catalyst concentration 60%, 70%, and 89% of dye degraded, for dye concentration (5 mg/L to 50 mg/L), the huge variation observed (70% to 22%), (80% to 16%), (94% to 10%). The highest photodegradation rate (55%, 75%, 90%) was observed on pH~12 using ZnO, CoZnO, and CuZnO respectively. Photodegradation of methylene blue confirmed the largest surface area, rate of recombination, photo-excited charge carriers, photo-sensitivity range, and radical generations of ZnO, CuZnO, and CoZnO. The present study, therefore, suggested that CuZnO would be preferred to produce nanomaterials for industrial wastewater treatment like methylene.

12 January 2021 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
STShams Tabrez
Shams Tabrez
FRFazlur Rahman
Fazlur Rahman
RARahat Ali
Rahat Ali
Abdulaziz AlouffiAbdulaziz Alouffi
Abdulaziz Alouffi
SASajjadul Kadir Akand
Sajjadul Kadir Akand
ARAbdur Rub
Abdur Rub
Cynaroside, a flavonoid, has been shown to have antibacterial, antifungal and anticancer activities. Here, we evaluated its antileishmanial properties and its mechanism of action through different in silico and in vitro assays. Cynaroside exhibited antileishmanial activity in time- and dose-dependent manner with 50% of inhibitory concentration (IC50) value of 49.49 ± 3.515 µM in vitro. It inhibited the growth of parasite significantly at only 20 µM concentration when used in combination with miltefosine, a standard drug which has very high toxicity. It also inhibited the intra-macrophagic parasite significantly at low doses when used in combination with miltefosine. It showed less toxicity than the existing antileishmanial drug, miltefosine at similar doses. Propidium iodide staining showed that cynaroside inhibited the parasites in G0/G1 phase of cell cycle. 2,7-dichloro dihydro fluorescein diacetate (H2DCFDA) staining showed cynaroside induced antileishmanial activity through reactive oxygen species (ROS) generation in parasites. Molecular-docking studies with key drug targets of Leishmania donovani showed significant inhibition. Out of these targets, cynaroside showed strongest affinity with uridine diphosphate (UDP)-galactopyranose mutase with −10.4 kcal/mol which was further validated by molecular dynamics (MD) simulation. The bioactivity, ADMET (absorption, distribution, metabolism, excretion and toxicity) properties, Organisation for Economic Co-operation and Development (OECD) chemical classification and toxicity risk prediction showed cynaroside as an enzyme inhibitor having sufficient solubility and non-toxic properties. In conclusion, cynaroside may be used alone or in combination with existing drug, miltefosine to control leishmaniasis with less cytotoxicity.

27 November 2020 in Animals
Verified
Journal Article
Open access
PDF file
Ahmed A. A. Abdel-WarethAhmed A. A. Abdel-Wareth
Ahmed A. A. Abdel-Wareth
MKMohammed Al Kahtani
Mohammed Al Kahtani
KAkhalid Alsyaad
khalid Alsyaad
FSFatma Mohsen Shalaby
Fatma Mohsen Shalaby
Islam SaadeldinIslam Saadeldin
Islam Saadeldin
AEAhmed Ezzat
Ahmed Ezzat
The present study aimed to determine the effects of zinc oxide nanoparticles (ZnO-NPs), thyme oil (THO), or their combination on the nutrient digestibility coefficients, reproductive parameters, and some blood metabolites of male Californian rabbits. One hundred rabbits, 29-weeks of age (initial body weight 3.48 ± 0.08 kg) were randomly distributed into four groups, 25 rabbits each. Treatment groups were fed a control diet, a control diet supplemented with ZnO-NPs (100 mg/kg), THO (500 mg/kg), or combination of ZnO-NPs (100 mg/kg) and THO (500 mg/kg). The feeding trial lasted for 35 days. Results showed improvements in dry matter, crude protein, ether extract, and crude fiber in ZnO-NPs, THO, and their combination treated groups compared to those of control. Furthermore, semen volume, sperm motility, vitality, and morphology were significantly improved (p < 0.01) in ZnO-NPs and THO groups rather than the control. Both ZnO-NPs and THO, as either individual or combined treatments significantly improved the serum alanine amino-transferase (ALT), aspartate amino-transferase (AST), urea, and creatinine compared to the control. Moreover, serum concentrations of testosterone were significantly increased in rabbits supplemented with ZnO-NPs, THO, or their combination compared to those of control (p < 0.05). In conclusion, ZnO-NPs, THO, or their combination improved the digestibility of nutrients, liver/ kidney functions, semen characteristics, and testosterone concentration in male rabbits.
1

6 August 2024 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
MTMedhat Abo tahon
Medhat Abo tahon
FAFahdah Ayed Alshammari
Fahdah Ayed Alshammari
ISIsmail Mahmoud Shahhat
Ismail Mahmoud Shahhat
MGMohamed Ghareib
Mohamed Ghareib
WAWafaa E. Abdallah
Wafaa E. Abdallah

22 December 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
AAAbid Ali
Abid Ali
SAShabir Ahmad
Shabir Ahmad
PAPedro Machado Medeiros de Albuquerque
Pedro Machado Medeiros de Albuquerque
AKAtif Kamil
Atif Kamil
FAFahdah Ayed Alshammari
Fahdah Ayed Alshammari
Itabajara da Silva Vaz JuniorItabajara da Silva Vaz Junior
Itabajara da Silva Vaz Junior
The emergence of drug-resistant lice, acari, and their associated pathogens (APs) is associated with economic losses; thus, it is essential to find new appropriate therapeutic approaches. In the present study, a subtractive proteomics approach was used to predict suitable therapeutics against these vectors and their infectious agents. We found 9701 proteins in the lice (Pediculus humanus var. corporis) and acari (Ixodes scapularis, Leptotrombidium deliense), and 4822 proteins in the proteomes of their APs (Babesia microti, Borreliella mayonii, Borrelia miyamotoi, Borrelia recurrentis, Rickettsia prowazekii, Orientia tsutsugamushi str. Boryong) that were non-homologous to host proteins. Among these non-homologous proteins, 365 proteins of lice and acari, and 630 proteins of APs, were predicted as essential proteins. Twelve unique essential proteins were predicted to be involved in four unique metabolic pathways of lice and acari, and 103 unique proteins were found to be involved in 75 unique metabolic pathways of APs. The sub cellular localization analysis of 115 unique essential proteins of lice and acari and their APs revealed that 61 proteins were cytoplasmic, 42 as membrane-bound proteins and 12 proteins with multiple localization. The druggability analysis of the identified 73 cytoplasmic and multiple localization essential proteins revealed 22 druggable targets and 51 novel drug targets that participate in unique pathways of lice and acari and their APs. Further, the predicted 42 membrane bound proteins could be potential vaccine candidates. Screening of useful inhibitors against these novel targets may result in finding novel compounds efficient for the control of these parasites.